Nov 01 2024
The percentage of U.S. adults who report they smoke marijuana has more than doubled since 2013, when Gallup first added the question to its annual Consumption Habits survey. That year, 7% said they smoke it.
Marijuana use varies significantly by gender, age and other respondent characteristics:
Continue reading
Nov 01 2024
According to the New Mexico Regulation & Licensing Department, there was $46,821,699.23 worth of marijuana sold in October, spread across 1,180,263 different transactions. This bring the year-to-date total for marijuana sales to around $440 million.
All-time sales are now $1,361,057,802.03, spread across 29,705,041 different transactions.
Continue reading
Nov 01 2024
These measures, if approved, could bring significant changes to local and state marijuana policies. This includes potentially adding to the 38 states that have legalized medical marijuana, and the 24 that have legalized recreational marijuana.
With that in mind, below is a breakdown of every state and city voting on marijuana proposals on November 5.
Continue reading
Nov 01 2024
According to data released by Statistics Canada, there was $465.1 million Canadian dollars (CA) worth of marijuana and marijuana products sold legally throughout August, an increase from the $453 million sold in July, but a slight drop from the $469 million sold in August 2024.
The year-to-date total for marijuana sales in Canada is now over $3.3 billion.
Continue reading
Nov 01 2024
Sour Diesel (photo credit: Leafly.com).
Drawing on recent data from state regulatory agencies and popular sites that track strain popularity such as Leafly, below is a list of the most popular marijuana strains in the U.S. as of November 2024. The list remains similar to the top strains from October, with some notable shakeups, including a change in the top spot.
Continue reading
Oct 31 2024
This decision comes as the state prepares to roll out its medical cannabis program in early 2025, following its recent legalization. Local jurisdictions that vote in favor will set the groundwork for dispensaries, cultivation sites, and other medical cannabis operations.
Here’s a look at the cities and counties facing this pivotal decision.
Continue reading
Oct 31 2024
Although DEA Administrator Anne Milgram approved over 20 participants for the agency’s rescheduling hearing, Chief Administrative Law Judge (ALJ) John Mulrooney issued a preliminary order Thursday, requesting additional information from witnesses, including their availability for a potential hearing in January or February. Participants are being told to respond by November 12.
While an initial meeting will still occur on December 2, the ALJ clarified that no testimony or evidence collection will occur during that session, but instead will take place during the January or February meeting yet to be scheduled.
Oct 31 2024
Dried psilocybin mushrooms.
Published in the Journal of Psychopharmacology, the study was conducted by researchers from Alborz University of Medical Sciences, Tehran University of Medical Sciences, and Shahid Beheshti University of Medical Sciences, all in Iran.
“Due to the unsatisfactory therapeutic effects of current antidepressants, research has been launched into alternative treatment approaches, such as the administration of psychedelics”, states the study. “Psilocybin, a classic hallucinogen, has been shown to exert considerable positive influence on depression symptoms through its serotonergic and glutamatergic effects. This systematic review and meta-analysis aimed to evaluate the effectiveness of psilocybin in treating depression.”
Continue reading
Oct 31 2024
The poll found that only 33% of adults in Canada oppose marijuana legalization, with 5% undecided. Support for legal marijuana remains highest in Quebec (66%), Alberta (64%), and Ontario (64%). In comparison, Saskatchewan and Manitoba trail with 53% in favor. Among different ethnic backgrounds, Canadians of Indigenous and European descent are more likely to support legalization, at 75% and 67%, respectively.
The survey of 1,001 Canadians aged 18 and older also found that marijuana usage remains mixed. Over half of Canadians (52%) reported not consuming marijuana since legalization, while a third (33%) had used it before it became legal, and 14% began only afterward. Notably, among those who do consume, only 51% report buying exclusively from licensed retailers, with Alberta, Saskatchewan, and Ontario leading the provinces in licensed purchases, while British Columbia lags with 39%.
Continue reading
Oct 31 2024
Mescaline (top left), ibogaine (top right), psilocybin mushrooms (bottom left), and DMT (bottom right). All four would be legalized if Question 4 is approved.
The poll, released just days prior to the November 5 presidential election, found that 50% of likely voters in Massachusetts plan to vote yes on Question 4, with 44% planning to vote no and 6% undecided.
The survey was conducted between October 24 to 26, and included 1,000 participants, all likely voters. The poll has a margin of error of +/- 3%. The data sets were weighted by gender, education, race, age, party registration, and region based on 2024 likely voter modeling. Turnout modeling is based on U.S. Census parameters, exit polling, and voter registration data.
Continue reading
